advertisement

WGA Rescources

Disclosure

Reviewers were asked the following:

My relationship to the industry regarding the material to be presented is as follows.
(Check all applicable items. List the specific relationships at the end.)

There is no industry connection to this material. I am a paid consultant, or have received honoraria or other compensation (e.g. travelling costs, speaker's fee) from a corporation that may be affected by this comment (positively or negatively). I am (or a member of my family is) a stockholder in a corporation that may be affected by this comment (positively or negatively).  I receive support from the industry for research related to the subject of my comment.
  • No conflict of interest for writing this comment/report in IGR
    Acott, Alward, Boden, Bowd, Brandt, Burgoyne, Chauhan, Crowston, Danias, Fingeret, Harris, Harwerth, Hernandez, Hood, Johnson, Krieglstein, Medeiros, Michelson, Quigley, Robin, Shah, Tamm, Tuulonen, Yamamoto
     
  • Disclosed:
    • Camras: ad hoc consultant to Pfizer and Alcon. Support for research from Pfizer, Alcon, Allergan and Novartis
    • Greve: Intensive contacts with: Alcon (1, 2), Allergan (1, 2), CZM (1,2), Haag-Streit (1, 2), Heidelberg (1, 2), LDT (1, 2), Medtronic (1, 2), Merck (1), Novartis (1), Pfizer (1, 2, 3), R-Tech Ueno (1, 2), Santen USA/JP (1, 2), Ziemer (1, 2);
      1 = WGA; 2 = IGR; 3 = consultant
    • Hare: full time Allergan employee
    • Kaufman: I am a paid consultant or have received honoraria or other compensation (e.g. travel, speaker fee) from a corporation that may be affected by this comment (positively or negatively). Paid advisor to Pfizer, Alcon, Allergan and Santen, research and travel support from all these companies
    • Khaw: Professor P.T. Khaw has/has had research funding from Cambridge Antibody Technology for research into Trabio (TGF beta 2 antibody) Polytherics for research into nanomolecules to prevent inflammation and scarring, ISIS Pharmaceuticals for research into antisense molecules, and research funding as an inventor of the use of matrix metalloproteinase inhibitors to prevent scarring after surgeryPatella: I am a full-time employee of Carl Zeiss Meditec, Inc, and own stock in the corporation as well
    • Migdal: I am on the Allergan Glaucoma Advisory Board, a Merck Editorial Board, and Faculty Member for Alcon, Allergan, Merck and Pfizer. I currently receive research grants from Cambridge Antibody Technology (TGF beta study) and Allergan (Memantine)
    • Gail Schwartz: Have received research funding, honoraria, and travel expenses from Pfizer. Have received research funding from Allergan, Alcon, Santen. Received honoraria from Allergan, Merck
    • Wheeler: full time Allergan employee
       
  • No information received from:
    Weinreb

Issue 6-3

Change Issue


advertisement

Topcon